HUTCHMED (China) Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US44842L1035
9,70 € ↓ -0,15 (-1,52%)
2026-06-03
AKTIENPREIS
SecurityDE:H7T1 / HUTCHMED (China) Limited - Depositary Receipt (Common Stock)
InstitutionCitigroup Inc
Latest Disclosed Ownership191 shares
Latest Disclosed Value $ 2,857
Citigroup Inc reports 0.52% decrease in ownership of H7T1 / HUTCHMED (China) Limited - Depositary Receipt (Common Stock)

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 191 shares of HUTCHMED (China) Limited - Depositary Receipt (Common Stock) (DE:H7T1) valued at $2,349 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 192 shares of HUTCHMED (China) Limited - Depositary Receipt (Common Stock). This represents a change in shares of -0.52% during the quarter. The current value of the position is $1,853 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 191 -1 -0.52 3 0.00 0.0000
2026-02-13 2025-12-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 192 -596 -75.63 3 -83.33 0.0000
2025-11-10 2025-09-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 788 5 0.64 12 9.09 0.0000
2025-08-11 2025-06-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 783 138 21.40 12 22.22 0.0000
2025-05-12 2025-03-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 645 -70 -9.79 10 -10.00 0.0000
2025-02-12 2024-12-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 715 -29 -3.90 10 -28.57 0.0000
2024-11-12 2024-09-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 744 -107 -12.57 15 0.00 0.0000
2024-08-12 2024-06-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 851 543 176.30 15 180.00 0.0000
2024-05-10 2024-03-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 308 -447 -59.21 5 -61.54 0.0000
2024-02-09 2023-12-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 755 154 25.62 14 30.00 0.0000
2023-12-06 2023-09-30 13F/A-1 HUTCHMED CHINA SPONSORED ADS 44842L103 601 -1,512 -71.56 10 -60.00 0.0000
2023-11-09 2023-09-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 601 -1,512 10 0.0000
2023-08-10 2023-06-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 2,113 -15,528 -88.02 25 -89.08 0.0000
2023-05-11 2023-03-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 17,641 14,928 550.24 230 472.50 0.0002
2023-02-09 2022-12-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 2,713 -13,514 -83.28 40 -72.03 0.0000
2022-11-10 2022-09-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 16,227 -13,400 -45.23 143 -61.87 0.0001
2022-08-10 2022-06-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 29,627 -968 -3.16 375 -35.23 0.0003
2022-05-12 2022-03-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 30,595 -4,642 -13.17 579 -53.16 0.0004
2022-02-10 2021-12-31 13F HUTCHMED CHINA SPONSORED ADS 44842L103 35,237 1,565 4.65 1,236 0.24 0.0007
2021-11-10 2021-09-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 33,672 2,664 8.59 1,233 1.23 0.0007
2021-08-10 2021-06-30 13F HUTCHMED CHINA SPONSORED ADS 44842L103 31,008 -3,101 -9.09 1,218 26.48 0.0007
2021-05-13 2021-03-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 34,109 -11,966 -25.97 963 -34.76 0.0006
2021-02-11 2020-12-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 46,075 2,991 6.94 1,476 6.11 0.0009
2020-11-12 2020-09-30 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 43,084 -5,172 -10.72 1,391 4.51 0.0009
2020-08-12 2020-06-30 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 48,256 1,344 2.86 1,331 58.83 0.0010
2020-05-12 2020-03-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 46,912 -6,331 -11.89 838 -37.23 0.0008
2020-02-12 2019-12-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 53,243 40,993 334.64 1,335 509.59 0.0010
2019-11-08 2019-09-30 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 12,250 -4,434 -26.58 219 -40.49 0.0002
2019-08-12 2019-06-30 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 16,684 -4,569 -21.50 368 -43.38 0.0003
2019-05-13 2019-03-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 21,253 5,716 36.79 650 81.06 0.0006
2019-02-12 2018-12-31 13F HUTCHISON CHINA MEDITECH SPONSORED ADR 44842L103 15,537 15,537 359 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.